Quick Answer
BIOLARGO, INC. reported Research And Development Expense of $2.59 million for the year ending 2025.
- BIOLARGO, INC. showed a decrease of -10.0% in Research And Development Expense from 2024 to 2025.
- This data is from BIOLARGO, INC.'s annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), BIOLARGO, INC.'s Research And Development Expense has grown by 2,478.5%.
- Historical annual values: Fiscal year 2025: $2.59 million | Fiscal year 2024: $2.88 million | Fiscal year 2023: $2.28 million | Fiscal year 2022: $1.32 million | Fiscal year 2021: $1.37 million | Fiscal year 2020: $1.34 million | Fiscal year 2019: $1.47 million | Fiscal year 2018: $1.72 million | Fiscal year 2017: $1.63 million | Fiscal year 2016: $1.38 million | Fiscal year 2015: $684.6 thousand | Fiscal year 2014: $642.9 thousand | Fiscal year 2013: $742.2 thousand | Fiscal year 2012: $383.5 thousand | Fiscal year 2011: $99.5 thousand | Fiscal year 2010: $100.6 thousand.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: